Cite
Schreiber JM, Wiggs E, Cuento R, et al. A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. J Child Neurol. 2021;36(13):1189-1199doi: 10.1177/08830738211012804.
Schreiber, J. M., Wiggs, E., Cuento, R., Norato, G., Dustin, I. H., Rolinski, R., Austermuehle, A., Zhou, X., Inati, S. K., Gibson, K. M., Pearl, P. L., & Theodore, W. H. (2021). A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. Journal of child neurology, 36(13), 1189-1199. https://doi.org/10.1177/08830738211012804
Schreiber, John M, et al. "A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency." Journal of child neurology vol. 36,13 (2021): 1189-1199. doi: https://doi.org/10.1177/08830738211012804
Schreiber JM, Wiggs E, Cuento R, Norato G, Dustin IH, Rolinski R, Austermuehle A, Zhou X, Inati SK, Gibson KM, Pearl PL, Theodore WH. A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. J Child Neurol. 2021 Nov;36(13):1189-1199. doi: 10.1177/08830738211012804. Epub 2021 May 20. PMID: 34015244; PMCID: PMC8605041.
Copy
Download .nbib